Cashu | News | RGNX

HomeWatchlistNewsSignalsPicks

DJI

-1.79%

SPX

-1.13%

IXIC

-1.30%

FTSE

-0.39%

N225

-0.89%

AXJO

-0.21%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Regenxbio News

A Glimpse Into The Expert Outlook On Regenxbio Through 8 Analysts

Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com

Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday

Feature Image for interests on Basic Materials, Big Gainers, Healthcare, Mid Day Movers from benzinga.com

finance.yahoo.com

REGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024

Feature Image for interests on -- Regenxbio Inc., Arshad Khanani, Durable Treatment Effect, Gene Therapy from finance.yahoo.com

finance.yahoo.com

Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Feature Image for interests on Cancer Patients, Chief Executive Officer, Chief Scientific Officer, Development from finance.yahoo.com

finance.yahoo.com

REGENXBIO Appoints Mitchell Chan as Chief Financial Officer

Feature Image for interests on Chan, Executive Vice President, Gene Therapy, Healthcare from finance.yahoo.com

finance.yahoo.com

RegenxBio touts positive data for rare disease drug RGX-121

Feature Image for interests on Cerebrospinal Fluid, Dose Escalation Study, Dose Level, Gene Therapy from finance.yahoo.com

finance.yahoo.com

RegenxBio touts positive data for rare disease drug RGX-121

Feature Image for interests on Cerebrospinal Fluid, Dose Escalation Study, Dose Level, Gene Therapy from finance.yahoo.com

finance.yahoo.com

REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect

Feature Image for interests on Gene Therapy, Healthcare, Mps Ii, Mucopolysaccharidosis Type from finance.yahoo.com

finance.yahoo.com

REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium

Feature Image for interests on Clinical Update, Healthcare, Medical Genetics Service, Mucopolysaccharidosis Type from finance.yahoo.com

Stocks

Health Care

rgnx

Regenxbio

RGNX

-0.93 (-9.12%)

9.27

USD

At close at Jun 13, 20:41 UTC

Latest Cashu News

Regenxbio: Navigating Mixed Analyst Sentiment in Gene Therapy Innovations

RegenXBio's RGX-202 Shows Promise in Duchenne Muscular Dystrophy Gene Therapy Trial

RegenXBio's RGX-202 Shows Promise in Duchenne Muscular Dystrophy Gene Therapy Trials